Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial
Titel:
Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial
Auteur:
Powles, Thomas Choueiri, Toni K Albiges, Laurence Peltola, Katriina de Velasco, Guillermo Burotto, Mauricio Suarez, Cristina Ghatalia, Pooja Iacovelli, Roberto Lam, Elaine T Verzoni, Elena Gümüş, Mahmut Stadler, Walter M Kollmannsberger, Christian Melichar, Bohuslav Venugopal, Balaji Gross-Goupil, Marine Poprach, Alexandr De Santis, Maria Rizzo, Mimma Shinde, Reshma Saretsky, Todd L He, Li Perini, Rodolfo F Vickery, Donna Rini, Brian